» Articles » PMID: 37129834

The Human Microbiome and Gut-liver Axis in People Living with HIV

Overview
Publisher Current Science
Date 2023 May 2
PMID 37129834
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Chronic liver disease is a major cause of morbidity and mortality amongst people living with HIV (PLWH). Emerging data suggests that gut microbial translocation may play a role in driving and modulating liver disease, a bi-directional relationship termed the gut-liver axis. While it is recognized that PLWH have a high degree of dysbiosis and gut microbial translocation, little is known about the gut-liver axis in PLWH.

Recent Findings: Recent studies have shown that microbial translocation can directly lead to hepatic inflammation, and have linked gut microbial signatures, dysbiosis, and translocation to liver disease in PLWH. Additionally, multiple trials have explored interventions targeting the microbiome in PLWH. Emerging research supports the interaction between the gut microbiome and liver disease in PLWH. This offers new opportunities to expand our understanding of the pathophysiology of liver disease in this population, as well as to explore possible clinical interventions.

Citing Articles

Alterations in the Gut Microbiome Composition of People Living with HIV in the Asia-Pacific Region: A Systematic Review.

Salvador P, Altavas P, Del Rosario M, Ornos E, Dalmacio L Clin Pract. 2024; 14(3):846-861.

PMID: 38804398 PMC: 11130874. DOI: 10.3390/clinpract14030066.

References
1.
Campos-Varela I, Dodge J, Terrault N, Brandman D, Price J . Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus. Am J Transplant. 2021; 21(9):3148-3156. PMC: 8522205. DOI: 10.1111/ajt.16569. View

2.
Koo H, DuPont H, Huang D . The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea. Ther Clin Risk Manag. 2009; 5:841-8. PMC: 2773752. DOI: 10.2147/tcrm.s4442. View

3.
Noureddin M, Ntanios F, Malhotra D, Hoover K, Emir B, McLeod E . Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learning. Hepatol Commun. 2022; 6(7):1537-1548. PMC: 9234676. DOI: 10.1002/hep4.1935. View

4.
Maurice J, Manousou P . Non-alcoholic fatty liver disease. Clin Med (Lond). 2018; 18(3):245-250. PMC: 6334080. DOI: 10.7861/clinmedicine.18-3-245. View

5.
Le Roy T, Llopis M, Lepage P, Bruneau A, Rabot S, Bevilacqua C . Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut. 2012; 62(12):1787-94. DOI: 10.1136/gutjnl-2012-303816. View